Reyoung Pharmaceutical Co., Ltd. >> Ciprofloxacine, Griseofulivin Tablets (0.5G/7ML VIAL, 1.0G/7ML or 10ML VIAL, 12-32ML VIAL)

Ciprofloxacine, Griseofulivin Tablets (0.5G/7ML VIAL, 1.0G/7ML or 10ML VIAL, 12-32ML VIAL)

Ciprofloxacine, Griseofulivin Tablets (0.5G/7ML VIAL, 1.0G/7ML or 10ML VIAL, 12-32ML VIAL)
Price: Negotiable
Min Order: 1
We can manufacture anotibiotics, vitamins. And the preparation such as Power for injection, small volume injection, lyophilized injection, tablets, capsules, oral suspension, etc.
Prod Model: 0.5G/7ML VIAL, 1.0G/7ML or 10ML VIAL, 12-32ML VIAL
Established in 1966, Reyoung Pharmaceutical Co., Ltd. (Reyoung Pharm) is a specialized high-tech manufacturer of powder injections. With total net assets of USD29, 640, 000 and more than 4, 000 skilled employees, we are one of the top manufacturers of Mezlocillin Sodium in China, which has been listed in China Torch Program. Additionally, the annual turnover has exceeded USD51, 450, 000 since 2004, and the export values are around 13.3% against total turnover.

Specifically, we are able to supply more than 200 kinds of finished products and over 10 kinds of raw materials. The form of finished products includes tablet, capsule, granule, suppository, parenteral solution, powder for injection and lyophilized powder for injection. Meanwhile, the annual output reaches 1, 000, 000, 000 vials of powder injection, 2, 500, 000, 000 tablets, 300, 000, 000 ampoules of parenteral solution and 200, 000, 000 capsules. Moreover, raw materials include Mezlocillin Sodium, Piperacillin Sodium, Cefotaxime Sodium, Ceftriaxone Sodium and Cefoperazone Sodium. Noticeably, we have built up a new plant with annual output capacity of 500 tons Cephalosporins.

Having obtained the Chinese GMP (Good Manufacturing Practices) certificate, our products are ISO9001, ISO14001 and OHSAS18001 certified. The establishment of strict quality control system and management system has ensured product quality comply with the BP, USP and CP standards. Consequently, our products are selling well in the South American, Southeast Asian, the Middle East and African markets, and have been registered in Uganda, Nigeria, Pakistan, Turkey, Chile and Southeast Asian countries. Based on the development of 'Science and Technology', we have invested about RMB3, 000, 000 every year on research and development of new product series and technology. Furthermore, the China Ministry of Personnel has set up a postdoctoral workstation in our company, which has been greatly improving the R&D capability.

Presently, we are looking forward to even greater cooperation with overseas customers based on mutual benefits. Please feel free to contact us or visit our website for more information.

Send your message to this manufacturer

  • Reyoung Pharmaceutical Co., Ltd.

More >

Other Products From This Manufacturer